Want to join the conversation?
$CCL 2Q15 Q&A Update – David, CFO: Trying to understand what’s going on versus the second quarter, yes we did beat by $0.12, but remember $0.03 of that was simply timing of expenses between the quarters. So on a fully year basis, it’s really $0.09 and we also had about $0.05 increase overall cost flowing through mainly advertising.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?